|

CARv3-TEAM-E T cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Autologous T lymphocyte

Pipeline

Phase 1: 1

Top Sponsors

  • Marcela V. Maus, M.D.,Ph.D.1

Indications

  • Recurrent Glioma1
  • Recurrent Glioblastoma1
  • Malignant Glioma1
  • Glioblastoma1
  • Cancer1

Boston, Massachusetts1 trial

CARv3-TEAM-E T Cells in Glioblastoma

Massachusetts General Hospital Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.